PHARMACOKINETICS OF IODAMIDE IN NORMAL SUBJECTS AND IN PATIENTS WITH RENAL IMPAIRMENT

被引：10
|
作者：
DIFAZIO, LT
SINGHVI, SM
HEALD, AF
MCKINSTRY, DN
BROSMAN, SA
GILLENWATER, JY
WILLARD, DA
机构：
[1] SQUIBB INST MED RES,DEPT CLIN PHARMACOL,NEW BRUNSWICK,NJ 08903
[2] UNIV CALIF LOS ANGELES,HARBOR GEN HOSP,DEPT SURG UROL,TORRANCE,CA 90509
[3] UNIV VIRGINIA,MED CTR,CHARLOTTESVILLE,VA 22903
[4] MED CTR,PRINCETON,NJ 08540
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1978年 / 18卷 / 01期
关键词：
D O I：
10.1002/j.1552-4604.1978.tb01558.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：35 / 41
页数：7
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF ENALAPRIL IN NORMAL SUBJECTS AND PATIENTS WITH RENAL IMPAIRMENT
    KELLY, JG
    DOYLE, G
    DONOHUE, J
    LAHER, M
    VANDENBURG, MJ
    CURRIE, WJC
    COOPER, WD
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 21 (01) : 63 - 69
  • [2] Pharmacokinetics of Teneligliptin in Subjects With Renal Impairment
    Halabi, Atef
    Maatouk, Haidar
    Siegler, Karl Ernst
    Faisst, Nadja
    Lufft, Volkmar
    Klause, Norbert
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (03): : 246 - 254
  • [3] Garenoxacin pharmacokinetics in subjects with renal impairment
    Krishna, Gopal
    Gajjar, Diptee
    Swan, Suzanne
    Marbury, Thomas
    Grasela, Dennis M.
    Wang, Zaiqi
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (03) : 649 - 657
  • [4] Pharmacokinetics of repaglinide in subjects with renal impairment
    Marbury, TC
    Ruckle, JL
    Hatorp, V
    Andersen, MP
    Nielsen, KK
    Huang, WC
    Strange, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (01) : 7 - 15
  • [5] Pharmacokinetics of teduglutide in subjects with renal impairment
    Nave, Ruediger
    Halabi, Atef
    Herzog, Rolf
    Schaffer, Peter
    Diefenbach, Joerg
    Krause, Stephan
    Berghoefer, Peter
    Lahu, Gezim
    Hartmann, Manfred
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 69 (05) : 1149 - 1155
  • [6] Pharmacokinetics of teduglutide in subjects with renal impairment
    Rüdiger Nave
    Atef Halabi
    Rolf Herzog
    Peter Schaffer
    Jörg Diefenbach
    Stephan Krause
    Peter Berghöfer
    Gezim Lahu
    Manfred Hartmann
    European Journal of Clinical Pharmacology, 2013, 69 : 1149 - 1155
  • [7] PHARMACOKINETICS OF CEFTAZIDIME IN HEALTHY-SUBJECTS AND IN PATIENTS WITH RENAL IMPAIRMENT
    LEROY, A
    FILLASTRE, JP
    HUMBERT, G
    BORSA, F
    LEGUY, F
    SPENCER, GR
    PRESSE MEDICALE, 1988, 17 (37): : 1917 - 1920
  • [8] Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment
    Robert J. Noveck
    Richard A. Preston
    Suzanne K. Swan
    Clinical Pharmacokinetics, 2007, 46 : 525 - 534
  • [9] PHARMACOKINETICS OF CEFPROZIL IN HEALTHY-SUBJECTS AND PATIENTS WITH RENAL IMPAIRMENT
    SHYU, WC
    PITTMAN, KA
    WILBER, RB
    MATZKE, GR
    BARBHAIYA, RH
    JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 31 (04): : 362 - 371
  • [10] Pharmacokinetics and safety of ebastine in healthy subjects and patients with renal impairment
    Noveck, Robert J.
    Preston, Richard A.
    Swan, Suzanne K.
    CLINICAL PHARMACOKINETICS, 2007, 46 (06) : 525 - 534
12345